|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
EBOOKCENTRAL_ocn705945748 |
| 003 |
OCoLC |
| 005 |
20240329122006.0 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
110307s2009 nyu ob 001 0 eng d |
| 040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d OCLCQ
|d YDXCP
|d E7B
|d OCLCF
|d OCLCQ
|d NLGGC
|d EBLCP
|d OCLCQ
|d OCLCO
|d OCLCQ
|d DEBSZ
|d OCLCQ
|d D6H
|d AZK
|d AGLDB
|d MOR
|d PIFAG
|d ZCU
|d MERUC
|d OCLCQ
|d AL5MG
|d OCLCQ
|d OCLCO
|d OCLCA
|d U3W
|d OCLCO
|d STF
|d WRM
|d VTS
|d OCLCO
|d NRAMU
|d ICG
|d VT2
|d REC
|d AU@
|d OCLCQ
|d OCLCO
|d WYU
|d TKN
|d DKC
|d OCLCQ
|d M8D
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCA
|d OCLCQ
|d OCLCA
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCL
|
| 019 |
|
|
|a 961600188
|a 962584230
|a 1058107921
|
| 020 |
|
|
|a 9781613243725
|q (electronic bk.)
|
| 020 |
|
|
|a 1613243723
|q (electronic bk.)
|
| 020 |
|
|
|z 9781606928431
|
| 020 |
|
|
|z 1606928430
|
| 029 |
1 |
|
|a AU@
|b 000051366735
|
| 029 |
1 |
|
|a DEBBG
|b BV044088219
|
| 029 |
1 |
|
|a DEBSZ
|b 456600337
|
| 029 |
1 |
|
|a DEBSZ
|b 472532278
|
| 029 |
1 |
|
|a NZ1
|b 15346363
|
| 035 |
|
|
|a (OCoLC)705945748
|z (OCoLC)961600188
|z (OCoLC)962584230
|z (OCoLC)1058107921
|
| 043 |
|
|
|a n-us---
|
| 050 |
|
4 |
|a RS55.2
|b .G465 2009eb
|
| 060 |
|
4 |
|a QV 55
|b G3265 2009
|
| 072 |
|
7 |
|a BUS
|x 070130
|2 bisacsh
|
| 082 |
0 |
4 |
|a 338.4/76151
|2 22
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a Generic drugs :
|b needs and issues /
|c Ryan S. Blanton, editor.
|
| 260 |
|
|
|a HNew York :
|b Nova Science Publishers,
|c ©2009.
|
| 300 |
|
|
|a 1 online resource (157 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Health care issues, costs and access series
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a Authorized generic pharmaceuticals : effects on innovation / Congressional Research Service -- Paying off generics to prevent competition with brand name drugs : should it be prohibited? -- Safe and affordable biotech drugs : the need for a generic pathway.
|
| 588 |
0 |
|
|a Print version record.
|
| 590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
| 650 |
|
0 |
|a Generic drugs
|z United States.
|
| 650 |
|
0 |
|a Generic drugs.
|
| 650 |
1 |
2 |
|a Drugs, Generic
|
| 650 |
2 |
2 |
|a Drug Industry
|x ethics
|
| 650 |
2 |
2 |
|a Government Regulation
|
| 650 |
2 |
2 |
|a Legislation, Drug
|
| 651 |
|
2 |
|a United States
|
| 650 |
|
6 |
|a Médicaments génériques
|z États-Unis.
|
| 650 |
|
6 |
|a Médicaments génériques.
|
| 650 |
|
7 |
|a BUSINESS & ECONOMICS
|x Industries
|x Pharmaceutical & Biotechnology.
|2 bisacsh
|
| 650 |
|
7 |
|a Generic drugs
|2 fast
|
| 651 |
|
7 |
|a United States
|2 fast
|1 https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq
|
| 700 |
1 |
|
|a Blanton, Ryan S.
|
| 776 |
0 |
8 |
|i Print version:
|t Generic drugs.
|d HNew York : Nova Science Publishers, ©2009
|z 9781606928431
|w (DLC) 2009027054
|w (OCoLC)317928022
|
| 830 |
|
0 |
|a Health care issues, costs, and access.
|
| 856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3019437
|z Texto completo
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL3019437
|
| 938 |
|
|
|a ebrary
|b EBRY
|n ebr10671002
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 357999
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 3647481
|
| 994 |
|
|
|a 92
|b IZTAP
|
